Description:

NSABP PROTOCOL C-08: BEVACIZUMAB TREATMENT FORM NCT00096278 Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=D7F6B84C-2C3E-4583-E034-0003BA12F5E7

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=D7F6B84C-2C3E-4583-E034-0003BA12F5E7

Keywords:
Versions (3) ▾
  1. 8/27/12
  2. 1/9/15
  3. 6/16/15
Uploaded on:

June 16, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

NSABP PROTOCOL C-08: BEVACIZUMAB TREATMENT FORM NCT00096278

Submit this form when a patient falls to start bevacizumab or when bevacizumab treatment has ended.

Header
Are data amended? (check box if yes, and circle amended items)
BEVACIZUMAB TREATMENT
Treatment Discontinued Type (select primary reason)
Adverse events which require discontinuation of bevacizumab
Comments

Similar models